¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"flat field objective"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • objective lens
    ´ë¹°·»Áî
  • objective micrometer
    ´ë¹°¹Ì¼¼ÀÚ, ´ë¹°¸¶ÀÌÅ©·Î¹ÌÅÍ
  • objective sensation
    °´°ü°¨°¢
  • objective sign
    °´°ü¡ÈÄ, Ÿ°¢Â¡ÈÄ
  • objective structured clinical examination
    °´°ü±¸Á¶È­Áø·á½ÃÇè
  • objective symptom
    °´°üÁõ»ó, Ÿ°¢Áõ»ó
  • objective tinnitus
    Ÿ°¢±Í¿ï¸², Ÿ°¢À̸í
  • objective vertigo
    Ÿ°¢Çö±âÁõ
  • auditory field
    û°¢¹üÀ§, û¿ª
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
  • complex receptive field
    º¹ÇÕ¼ö¿ë¾ß
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • objective
    ¸ñÀû, °´°ü, ´ë¹°·»Áî
  • objective sensation
    °´°ü°¨°¢
  • objective sign
    Ÿ°¢Â¡ÈÄ
  • objective symptom
    Ÿ°¢Áõ»ó
  • objective tinnitus
    Ÿ°¢±Í¿ï¸², Ÿ°¢À̸í
  • objective vertigo
    Ÿ°¢Çö±â, ÁÖÀ§¾îÁö·³
  • objective hearing test
    Ÿ°¢Ã»·Â°Ë»ç, °´°üÀûû·Â°Ë»ç
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • auditory field
    û°¢¹üÀ§, û¿ª
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
  • field block
    ºÎÀ§Â÷´Ü¸¶Ãë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • gravitational field
    Áß·ÂÀå(ñìæ³íÞ).
  • high field MR scanner
    °íÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • illumination, dark-field
    ¾Ï½Ã¾ßÁ¶¸í
  • point outside field
    Á¶»ç¿µ¿ª¹ÛÁöÁ¡
  • pulsed-field gel electrophoresis (PFGE)
    °£Çæ¾ß Àü±â¿µµ¿
  • radio-frequency field
    °íÁÖÆÄ ÀÚÀå
  • rectangular field of view (FOV)
    Á÷»ç°¢Çü ½Ã¾ß
  • relative field
    ºñ±³¿µ¿ª(ÝïÎòçÐæ´).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • objective symptom
    Ÿ°¢Áõ»ó(öâÊÆñøßÒ).
  • objective tinnitus
    Ÿ°¢(Àû) À̸í
  • objective toothache
    Ÿ°¢Àû Ä¡Åë(öâÊÆîÜöÍ÷Ô).
  • objective vertigo
    Ÿ°¢Àû Çö±â(öâÊÆîÜúßѨ).
  • test, objective hearing
    Ÿ°¢Àû û·Â°Ë»ç
  • tinnitus, objective
    Ÿ°¢(Àû) À̸í
  • ear, flat
    ÆíÆòÀÌ
  • flat
    ÆíÆò(ø·øÁ)ÇÑ, Æò¸é.
  • flat
    ÆòźÇÑ
  • flat affect
    Á¤¼­µÐ¸¶(ï×ßýÔïØ¦)
  • flat anterior chamber
    Àü¹æ¼Ò½Ç
  • flat bone
    ³³ÀÛ»À, ÆíÆò°ñ(ø·øÁÍé).
  • flat bone
    ³³ÀÛ»À
  • flat cornea
    ÆíÆò°¢¸·.
  • flat ear
    ÆíÆòÀÌ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • magnetic field
    ÀÚÀå(í¸íÞ)
  • pulsed-field gel electrophoresis
    ÆÞ½ºÀå(íÞ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • sedimentation field flow fractionation
    ħ°­Àå(öØË½íÞ) È帧ºÐȹ¹ý(ÝÂüñÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • FFE [=fast field echo]
    ±Þ¼ÓÀÚÀå¿¡ÄÚ
  • field
    ¾ß, ¿µ¿ª, Çʵå, Ç׸ñ
  • field echo
    ÀÚÀå¿¡ÄÚ
  • field gradient
    ÀÚÀå°æ»ç
  • field inhomogeneity
    ÀÚÀåºÒ±ÕÀÏ(¼º)
  • field of view [=FOV]
    ¿µ»ó¿µ¿ª, ¿µ»ó¹üÀ§
  • field profile
    ÀÚÀåÃø¸é»ó
  • field size
    Á¶»ç¾ßÅ©±â
  • field strength
    ÀÚÀå¼¼±â, ÀÚÀå·Â
  • field survey
    ÇöÁöÁ¶»ç
  • FOV [=field of view]
    ¿µ»ó¿µ¿ª, ¿µ»ó¹üÀ§
  • fringe field
    ÁÖº¯¾ß
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • gradient magnetic field
    °æ»çÀÚ±âÀå
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
BO Bachelor of Osteopathy; base of prism out; behavior objective; belladonna and opium; body odor; bowe...
MBO management by objective; mesiobucco-occlusal
OB obese [mouse]; obese, obesity; objective benefit; obliterative bronchiolitis; obstetrics, obstetrici...
obj objective
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AEF Auditory Evoked magnetic Field
CoMFA Comparative Molecular Field Analysis
CHEF Contour-clamped homogeneous electric field
DFM Dark field microscopy
E/MF electric and magnetic field
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • abutted field
    ÀÎÁ¢ Á¶»ç¸é
  • bright field photomicrograph
    ?
  • color field
    »ö ½Ã¾ß
  • constant field equation
    Á¤ÀüÀå ¹æÁ¤½Ä
  • cortical field
    ÇÇÁú ¿µ¿ª
  • dark-field microscope
    ¾Ï½Ã¾ß Çö¹Ì°æ
    ¾Ï½Ã¾ß Á¶¸í¹ý¿¡ ÀÇÇØ º¸ÅëÀÇ Çö¹Ì°æÀ¸·Î´Â º¸ÀÌÁö ¾Ê´Â ¹Ì¼¼ÇÑ ÀÔÀÚ¸¦ º¼ ¼ö ÀÖ´Â Çö¹Ì°æ. ÇÑ¿Ü Çö¹Ì°æÀ» ¸»Çϴµ¥, ¾Ï½Ã¾ß Á¶¸í°ú ±× Áý±¤ ·»Á »ç¿ëÇϹǷΠÀÌ¿Í °°ÀÌ ºÒ¸®±âµµ ÇÑ´Ù.
  • depository field
    ÷°¡ ¾ß
  • electromagnetic field
    ÀüÀÚÀå
    1. Àü±âÀå°ú ÀÚ±âÀåÀ» ÅëÆ²¾î ÁöĪÇÏ´Â ¸». 2. Àü±âÀå°ú ÀÚ±âÀåÀÌ ¼­·Î ¿¬°üµÇ¾î °°ÀÌ ³ªÅ¸³¯ ¶§ À̸£´Â ¸».
  • equivalent field
    µî°¡ Á¶»ç ¿µ¿ª
  • eye field
    ½Ã¾ß
  • far field
    ¿ø°Å¸® ±¸¿ª
  • field
    ±¸¿ª, ¾ß, ¿µ¿ª
    1. ÀÛ¿ë ¿µ¿ª ¶Ç´Â Àå¼Ò³ª °ø°£. 2. Áö½Ä, ¿¬±¸, Á÷¾÷¿¡ À־ÀÇ Àü¹® ºÐ¾ß. 3. ¹ß»ýÇп¡ ÀÖ¾î º¯µ¿ ¿äÀÎÀÇ ¹üÀ§ ³»¿¡¼­ ºÐÈ­ÇÏ´Â ¿µ¿ª.
  • field cancerization
    ±¸¿ª ¾ÏÈ­
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ, ÀÚÀå ºÒ±ÕÀϼº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
flat top waves Activity in the electroencephalogram having a pattern suggesting a flat top; these wave's are often found in temporal lobe discharges.
(05 Mar 2000)
flat wart A smooth, flat, flesh-coloured wart of small size, occurring in groups, seen especially on the face of the young; often associated with common warts of the hands, due to human papilloma virus, commonly, types 3 and 10.
Synonym: flat wart, plane wart, verruca plana juvenilis.
(05 Mar 2000)
achromatic objective <microscopy> An objective that is corrected chromatic for two colours, and spherically for one, usually in the yellow-green part of the spectrum.
(05 Aug 1998)
apochromatic objective <microscopy> A lens system whose secondary chromatic aberrations have been substantially reduced.
It is designed to provide the same focal length for three wavelengths and freedom from spherical aberration for two wavelengths of light. The magnification can still vary with wavelength in which case a compensating eyepieces used to cancel the coloured fringes.
(05 Aug 1998)
plan apochromatic objective lens <physics> A modern, high-numerical aperture microscope objective lens designed with high degrees of corrections for various aberrations. It is corrected for spherical aberration in four wavelengths (dark blue, blue, green, and red), for chromatic aberration in more than these four wavelengths, and for flatness of field. A single Plan Apo objective may contain as many as 11 lens elements.
(05 Aug 1998)
homogeneous immersion objective <microscopy> An objective to be immersed in a liquid of a certain refractive index and dispersion value as specified by the manufacturer of the objective. An oil-immersion objective, the most important type, is intended to be immersed in cedarwood oil (nD = 1.515) or in its manmade optical equivalent. A water-immersion objective is for dipping into an aqueous specimen mount. Alpha-monobromonaphthalene has such a high refractive index (nD = 1.66) that a very highly resolving objective (1.60 numerical aperture) was designed to be immersed in that liquid, for use by reflected light on metals and other opaque objects.
(05 Aug 1998)
semi-apochromatic objective <microscopy> A compromise, in the correction for chromatic and spherical aberration, between achromatic and apochromatic objectives, such as a fluorite objective.
(05 Aug 1998)
dry objective <microscopy> Any microscope objective designed for use without immersion liquids.
(05 Aug 1998)
immersion objective <microscopy> An objective in which the medium of high refractive index and is used in the object space to increase the numerical aperture and hence the resolving power of the lens.
See: homogeneous immersion of objective.
(05 Aug 1998)
objective 1. <psychology> Perceptible to the external senses.
2. <ophthalmology> The lens or system of lenses in a microscope (or telescope) that is nearest to the object under examination.
Origin: L. Objectivus
(18 Nov 1997)
objective assessment data Those facts presented by the client that show his/her perception, understanding and interpretation of what is happening.
(05 Mar 2000)
objective circle <microscopy> When the focused objective is examined by with- drawing the ocular and viewing its back focal plane through the microscope bodytube, the limiting boundary of the objective, the circumference of the white spot of light, is the objective circle.
(05 Aug 1998)
objective, fluorite <microscopy> An objective using the mineral fluorite in its construction. It is usually intermediate between achromatic and apochromatic in correction, but may be more highly corrected.
See: illumination, eyepiece.
(05 Aug 1998)
objective optometer <optics> A contrivance for exhibiting and measuring the refraction of light.
Origin: Refraction.
Source: Websters Dictionary
(01 Mar 1998)
objective perimetry Determination of the visual field by pupillary constriction, electroencephalography, or eye movements.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • flat money
    ¹ýÁ¤ºÒȯÁöÆó
  • flat race
    ÆòÁö °æÁÖ(°æ¸¶)
  • flat racing
    ÆòÁö°æÁÖ;ÆòÁö °æ¸¶
  • flat rate
    °íÁ¤(Á¤¾×)¿ä±Ý
  • flat roof
    ÆòÆòÇÑ ÁöºØ;ÆòÁöºØ
  • flat silver
    Àº±â
  • flat spin
    ¼öÆò ³ª¼± ¿îµ¿
  • flat tax
    ÀÏ·ü °ú¼¼
  • flat time sentence
    Á¤±â ±Ý°íÇü
  • flat tire
    ¹Ù¶÷ºüÁø ŸÀ̾î
  • flat trie
    ¹Ù¶÷ ºüÁø ŸÀ̾î
  • flat water
    Á¤¼ö¿ª
  • granny annex(flat)
    (º»Ã¤¿¡ ºÙÀº)³ëÀÎ Àü¿ëÀÇ µýä )
  • mud flat
    °³ÆÞ
  • railroad flat (apartment)
    ±âÂ÷°£½Ä ¾ÆÆÄÆ®(ÇÑ ÁÙ·Î À̾îÁø °¢ ¹æÀÌ ´ÙÀ½ ¹æÀ¸·Î °¡´Â Åë·Î°¡ µÇ´Â ½Î±¸·Á ¾ÆÆÄÆ®)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á